Hematoloxía e Hemoterapia
![Foto de Hematoloxía e Hemoterapia](/img/grupo.png)
![Foto de Hospital Universitario La Fe](/img/noimage_org.png)
Hospital Universitario La Fe
Valencia, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario La Fe (12)
2024
-
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice
Blood, Vol. 144, Núm. 6, pp. 646-656
2023
-
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
Haematologica
-
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)
Journal of Clinical Medicine, Vol. 12, Núm. 20
2022
-
Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products
Thrombosis Research, Vol. 216, pp. 35-42
2021
-
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients
Blood Cells, Molecules, and Diseases, Vol. 86
-
Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (Scientific Reports, (2019), 9, 1, (16680), 10.1038/s41598-019-53209-y)
Scientific Reports
-
Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study
Transplantation and Cellular Therapy, Vol. 27, Núm. 4, pp. 311.e1-311.e10
-
Management of acquired hemophilia A: results from the Spanish registry
Blood Advances, Vol. 5, Núm. 19, pp. 3821-3829
2020
-
Clinical, pharmacokinetic and economic analysis of the first switch to an extended half-life factor IX (albutrepenonacog alfa, rFIX-FP) in Spain
BMJ Case Reports, Vol. 13, Núm. 10
-
Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia
European Journal of Haematology, Vol. 104, Núm. 3, pp. 259-270
2019
-
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia
Scientific Reports, Vol. 9, Núm. 1
-
Joint status in Spanish haemophilia B patients assessed using the Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) score
Haemophilia, Vol. 25, Núm. 1, pp. 144-153